Stayble Therapeutics AB (publ) (STO:STABL)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0454
+0.0064 (16.41%)
Apr 28, 2026, 5:21 PM CET
-90.13%
Market Cap 2.92M
Revenue (ttm) n/a
Net Income (ttm) -6.93M
Shares Out 64.36M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,969,289
Average Volume 2,518,451
Open 0.0386
Previous Close 0.0390
Day's Range 0.0362 - 0.0828
52-Week Range 0.0274 - 0.5700
Beta -0.45
RSI 25.56
Earnings Date May 21, 2026

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) a clinical pharmaceutical company, developing an injection-based treatments for disc herniation. It develops STA363, an injection into the disc that targets chronic low back and leg pain. The company was incorporated in 2015 and is based in Gothenburg, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol STABL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.